Ras genes are pre-eminent genes that are frequently linked with cancer biology. The functional loss of ras protein caused by various point mutations within the gene, is established as a prognostic factor for the genesis of a constitutively active Ras-MAPK pathway leading to cancer. Ras signaling circuit follows a complex pathway, which connects many signaling molecules and cells. Several strategies have come up for targeting mutant ras proteins for cancer therapy, however, the clinical benefits remain insignificant. Targeting the Ras-MAPK pathway is extremely complicated due its intricate networks involving several upstream and downstream regulators. Blocking oncogenic Ras is still in latent stage and requires alternative approaches to screen the genes involved in Ras transformation. Understanding the mechanism of Ras induced tumorigenesis in diverse cancers and signaling networks will open a path for drug development and other therapeutic approaches.
Contents
-
Open AccessRas and Ras mutations in cancerApril 23, 2013
-
April 23, 2013
-
Open AccessDrosophila Nimrod proteins bind bacteriaApril 23, 2013
-
April 23, 2013
-
Open AccessBias, precision and validation of ageing 0+ European barbel Barbus barbus (L.) from their otolithsApril 23, 2013
-
April 23, 2013
-
Open AccessPalomena prasina (Hemiptera: Pentatomidae) vibratory signals and their tuning with plant substratesApril 23, 2013
-
Open AccessAssociation of mating-type with mycelium growth rate and genetic variability of Fusarium culmorumApril 23, 2013
-
April 23, 2013